Particle.news

Download on the App Store

Second Policymakers’ Forum Showcases India’s Role as Global Vaccine Supplier and Regulator

Delegates from 22 countries convened in Delhi to boost recognition of the Indian Pharmacopoeia for affordable medicine schemes

India accounts for 70% of WHO vaccine supply, 14% of US generic imports
Photo: IANS
Image
Image

Overview

  • India remains the leading supplier of vaccines to the WHO by providing 70% of its doses and supplies 14% of generics imported by the US.
  • Minister Anupriya Patel highlighted India’s retention of WHO GBT Maturity Level 3 status, reflecting the strength of its regulatory framework.
  • Fifteen countries, including recent entrant Cuba, recognize the Indian Pharmacopoeia as an official reference for drug standards.
  • Forum discussions centered on harmonizing pharmacopeial standards and strengthening global regulatory collaboration.
  • The IPC launched a digital coffee table book tracing its journey as India’s apex drug standards body and showcased Jan Aushadhi Kendras as models for affordable healthcare.